BRPI0417809A - forma de dosagem oral farmacêutica - Google Patents

forma de dosagem oral farmacêutica

Info

Publication number
BRPI0417809A
BRPI0417809A BRPI0417809-2A BRPI0417809A BRPI0417809A BR PI0417809 A BRPI0417809 A BR PI0417809A BR PI0417809 A BRPI0417809 A BR PI0417809A BR PI0417809 A BRPI0417809 A BR PI0417809A
Authority
BR
Brazil
Prior art keywords
dosage form
oral dosage
pharmaceutical oral
group
pharmaceutical
Prior art date
Application number
BRPI0417809-2A
Other languages
English (en)
Inventor
Leonardo Marchitto
Francesca Mariotti
Lorella Ragni
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of BRPI0417809A publication Critical patent/BRPI0417809A/pt
Publication of BRPI0417809B1 publication Critical patent/BRPI0417809B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"FORMA DE DOSAGEM ORAL FARMACêUTICA". Forma de dosagem oral farmacêutica que compreende trometamina e uma NSAID selecionada do grupo que compreende ibuprofen, naproxen e flurbiprofen, caracterizada pelo fato de que ela também compreende um composto selecionado do grupo que compreende glicina, vitamina B6 e misturas das mesmas.
BRPI0417809A 2003-12-19 2004-12-16 forma de dosagem oral farmacêutica BRPI0417809B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002523A ITMI20032523A1 (it) 2003-12-19 2003-12-19 Forma di dosaggio per uso orale comprendente un farmaco
PCT/EP2004/014465 WO2005058276A1 (en) 2003-12-19 2004-12-16 Pharmaceutical oral dosage form comprising a non-steroidal anti-inflammatory drug, and having goog palatability

Publications (2)

Publication Number Publication Date
BRPI0417809A true BRPI0417809A (pt) 2007-04-10
BRPI0417809B1 BRPI0417809B1 (pt) 2018-09-25

Family

ID=34685625

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417809A BRPI0417809B1 (pt) 2003-12-19 2004-12-16 forma de dosagem oral farmacêutica

Country Status (20)

Country Link
US (1) US9968552B2 (pt)
EP (1) EP1694295B1 (pt)
JP (1) JP4958558B2 (pt)
KR (1) KR101122174B1 (pt)
CN (1) CN100486643C (pt)
AR (1) AR048137A1 (pt)
AU (1) AU2004298763B2 (pt)
BR (1) BRPI0417809B1 (pt)
CA (1) CA2547194C (pt)
DK (1) DK1694295T3 (pt)
EA (1) EA009515B1 (pt)
ES (1) ES2388139T3 (pt)
IL (1) IL175827A0 (pt)
IT (1) ITMI20032523A1 (pt)
MX (1) MXPA06007052A (pt)
PL (1) PL1694295T3 (pt)
PT (1) PT1694295E (pt)
SI (1) SI1694295T1 (pt)
UA (1) UA83531C2 (pt)
WO (1) WO2005058276A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
ES2732729T3 (es) * 2014-12-25 2019-11-25 Sanovel Ilac Sanayi Ve Ticaret As Composiciones farmacéuticas acuosas tópicas orales de flurbiprofeno y dexpantenol
US20180228832A1 (en) * 2015-08-18 2018-08-16 Pharma Seeds Create, Llc Stomatological composition containing nsaid or heparin compound
EP3406239B1 (en) * 2017-05-22 2021-10-20 Epifarma Srl Palatable ketoprofen lysine salt solutions
CN111526868A (zh) 2017-11-30 2020-08-11 方济各安吉利克化学联合股份有限公司 酮洛芬及其盐和对映体的稳定的液体组合物
MX2022002353A (es) * 2019-08-26 2022-04-06 Dsm Ip Assets Bv Forma de dosificacion oral solida que comprende naproxeno y vitamina b1.
CN114129512B (zh) * 2021-12-14 2023-12-22 艾迈华创(武汉)科技有限公司 一种可口服用萘普生溶液制剂及其制备方法与应用
KR20230090186A (ko) 2021-12-14 2023-06-21 메디케어제약 주식회사 파라세타몰 및 나프록센을 포함하는 약제학적 복합제제

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4028772A (en) * 1971-04-02 1973-09-27 Merck & Co., Inc Chemical processes
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
JPH0768120B2 (ja) * 1987-03-09 1995-07-26 日清製粉株式会社 非ステロイド性抗炎症薬経口投与用組成物
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
US5183829A (en) * 1991-09-27 1993-02-02 Applied Analytical Industries, Inc. Oral liquid compositions of non-steroidal anti-inflammatory drugs
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
US5626838A (en) * 1995-03-13 1997-05-06 The Procter & Gamble Company Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
AU7637296A (en) * 1995-11-14 1997-06-05 Farmarc Nederland Bv Complex of naproxen and beta-cyclodextrin
GB9601398D0 (en) * 1996-01-24 1996-03-27 Piper Edwina M Composition
JPH11139970A (ja) * 1997-11-06 1999-05-25 Doujin Iyaku Kako Kk 経口液剤
US6426090B1 (en) * 1999-04-06 2002-07-30 Wm. Wrigley Jr. Company Over-coated product including tableted center and medicament
AR035642A1 (es) * 2000-05-26 2004-06-23 Pharmacia Corp Uso de una composicion de celecoxib para el alivio rapido del dolor
PT1411899E (pt) * 2001-08-01 2009-04-24 Novartis Ag Composição de mascaramento de sabor
ITMI20020986A1 (it) * 2002-05-10 2003-11-10 Acraf Composizione a base di diclofenac per il trattamento topico di affezioni del cavo orofaringeo
EP1974751A1 (en) 2007-03-26 2008-10-01 The Jordanian Pharmaceutical Manufacturing Co. Formulations for non-steroidal anti-inflammatory drugs

Also Published As

Publication number Publication date
IL175827A0 (en) 2006-10-05
ITMI20032523A1 (it) 2005-06-20
WO2005058276A1 (en) 2005-06-30
KR101122174B1 (ko) 2012-03-15
EP1694295A1 (en) 2006-08-30
BRPI0417809B1 (pt) 2018-09-25
JP4958558B2 (ja) 2012-06-20
SI1694295T1 (sl) 2012-10-30
ES2388139T3 (es) 2012-10-09
AU2004298763B2 (en) 2009-12-03
UA83531C2 (uk) 2008-07-25
EP1694295B1 (en) 2012-06-20
AR048137A1 (es) 2006-04-05
EA009515B1 (ru) 2008-02-28
KR20060120206A (ko) 2006-11-24
CN1893922A (zh) 2007-01-10
AU2004298763A1 (en) 2005-06-30
MXPA06007052A (es) 2007-01-30
HK1091404A1 (en) 2007-01-19
US20080292606A1 (en) 2008-11-27
DK1694295T3 (da) 2012-09-24
PT1694295E (pt) 2012-07-23
CN100486643C (zh) 2009-05-13
CA2547194C (en) 2011-12-13
CA2547194A1 (en) 2005-06-30
US9968552B2 (en) 2018-05-15
EA200601189A1 (ru) 2006-10-27
PL1694295T3 (pl) 2012-11-30
JP2007514701A (ja) 2007-06-07

Similar Documents

Publication Publication Date Title
IL166286A0 (en) Multicomponent pharmaceutical dosage form
DK1043977T3 (da) Oral farmaceutisk doseringsform baseret på pulserende frigørelse
EA200401169A1 (ru) Аминометилзамещенные тетрациклиновые соединения
ATE228009T1 (de) Orale, pharmazeutische darreichungsformen, die einen protonenpumpeninhibitor und ein antacidum oder alginat enthalten
IS6150A (is) Næringar- eða lyfjasamsetningar til nota við fyrirbyggingu eða meðhöndlun á ofurkalsíum oxalat myndun
DK1467724T3 (da) Farmaceutisk sammensætning med agomelatin til dispergering i mundhulen
DE60308372D1 (de) Dosierungsverabreichungsvorrichtung
DE60118008D1 (de) Pharmazeutische zusammensetzungen mit amlodipinmaleat
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
PT1185253E (pt) Forma de administracao oral para administracao de uma combinacao fixa de tramadol e diclofenac
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
ATE363840T1 (de) Capsaicinoid enthaltende pharmazeutische zusammensetzung zur oralen verabreichung
BRPI0417809A (pt) forma de dosagem oral farmacêutica
CL2003002653A1 (es) Composicion farmaceutica que comprende (a) un antiinflamatorio no esteroidal (nsaid), preferentemente ibuprofeno, (b) un descongestionante, preferentemente pseudoefedrina y (c) un antihistaminico, preferentemente clorfeniramina; metodo para su prepar
PT1159960E (pt) Composicoes farmaceuticas baseadas em diclofenac
DE60306747D1 (de) Perindopril enthaltende pharmazeutische zusammensetzung mit oraler dispersion
EA200501565A1 (ru) Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса
AU2003261067A8 (en) Modified release ketoprofen dosage form
NO20043633L (no) Oral doseringsform for kontrollert medikamentfrigivning
FR2839450B1 (fr) Preparation medicamenteuse notamment pour le traitement des hernies discales
RU2004135345A (ru) Фармацевтическая композиция для профилактики и дополнительной химиотерапии туберкулеза
ATE357220T1 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung
ITMI20030826A1 (it) Composizione farmaceutica contenente interferone per il
EP1556022A4 (en) Aqueous 2,6-diisopropylprophenol-containing pharmaceutical compositions
ES1053798Y (es) Dispositivo para la dosificacion de liquidos.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 25/09/2018, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2610 DE 12-01-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.